Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kjekshus

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
The American Journal of Medicine|May 10, 2001
Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjectsK B Holven, T Holm, P Aukrust, et al.
Circulation|May 15, 1996
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival StudyT R Pedersen, J Kjekshus, K Berg, et al.
Journal of Internal Medicine|January 4, 2012
The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*S H Nymo, T Ueland, E T Askevold, et al.
Circulation|February 24, 2001
Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failureL Gullestad, H Aass, J G Fjeld, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 8, 2001
[Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin]L Gullestad, H Aass, A K Andreassen, et al.
Clinical Pharmacology and Therapeutics|November 7, 2013
An investigation of CYP2D6 genotype and response to metoprolol CR/XL during dose titration in patients with heart failure: a MERIT-HF substudyJ A Batty, A S Hall, H L White, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cellsT Holm, J K Damås, K Holven, et al.
Archives of Internal Medicine|October 14, 1996
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival StudyT R Pedersen, K Berg, T J Cook, et al.
The American Journal of Cardiology|August 3, 2000
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol loweringT R Pedersen, L Wilhelmsen, O Faergeman, et al.
Circulation|May 12, 1998
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)T R Pedersen, A G Olsson, O Faergeman, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
The American Journal of Medicine|May 10, 2001
Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjectsK B Holven, T Holm, P Aukrust, et al.
Circulation|May 15, 1996
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival StudyT R Pedersen, J Kjekshus, K Berg, et al.
Journal of Internal Medicine|January 4, 2012
The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*S H Nymo, T Ueland, E T Askevold, et al.
Circulation|February 24, 2001
Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failureL Gullestad, H Aass, J G Fjeld, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 8, 2001
[Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin]L Gullestad, H Aass, A K Andreassen, et al.
Clinical Pharmacology and Therapeutics|November 7, 2013
An investigation of CYP2D6 genotype and response to metoprolol CR/XL during dose titration in patients with heart failure: a MERIT-HF substudyJ A Batty, A S Hall, H L White, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cellsT Holm, J K Damås, K Holven, et al.
Archives of Internal Medicine|October 14, 1996
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival StudyT R Pedersen, K Berg, T J Cook, et al.
The American Journal of Cardiology|August 3, 2000
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol loweringT R Pedersen, L Wilhelmsen, O Faergeman, et al.
Circulation|May 12, 1998
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)T R Pedersen, A G Olsson, O Faergeman, et al.
Pageof 17